{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T16:28:42Z","timestamp":1778603322229,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","ijdp.org","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.drugpo.2015.12.024","type":"journal-article","created":{"date-parts":[[2015,12,31]],"date-time":"2015-12-31T12:32:29Z","timestamp":1451565149000},"page":"57-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Non-prescribed use of opioid substitution medication: Patterns and trends in sub-populations of opioid users in Germany"],"prefix":"10.1016","volume":"29","author":[{"given":"Bernd","family":"Schulte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1999-2073","authenticated-orcid":false,"given":"Christiane S.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Strada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"G\u00f6tzke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Hiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedikt","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Reimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.drugpo.2015.12.024_bib0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/09595230701829553","article-title":"Buprenorphine injection in Melbourne Australia \u2013 An update","volume":"27","author":"Aitken","year":"2008","journal-title":"Drug and Alcohol Review"},{"issue":"1","key":"10.1016\/j.drugpo.2015.12.024_bib0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.drugalcdep.2006.09.012","article-title":"Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users","volume":"88","author":"Alho","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2015.12.024_bib0015","series-title":"Association of Drug Use Pattern with vulnerability and service uptake among IDUs New Delhi","author":"Ambekar","year":"2012"},{"issue":"1","key":"10.1016\/j.drugpo.2015.12.024_bib0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/dar.12208","article-title":"Type of opioids injected: Does it matter? A multicentric cross-sectional study of people who inject drugs","volume":"34","author":"Ambekar","year":"2015","journal-title":"Drug and Alcohol Review"},{"issue":"3","key":"10.1016\/j.drugpo.2015.12.024_bib0025","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/ADM.0b013e3182034e31","article-title":"Illicit use of buprenorphine\/naloxone among injecting and noninjecting opioid users","volume":"5","author":"Bazazi","year":"2011","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.drugpo.2015.12.024_bib0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/09595230096093","article-title":"Use of non-prescribed methadone and other illicit drugs during methadone maintenance treatment","volume":"19","author":"Best","year":"2000","journal-title":"Drug and Alcohol Review"},{"issue":"2","key":"10.1016\/j.drugpo.2015.12.024_bib0035","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3109\/16066359.2010.490310","article-title":"Toxicology of Scotland's drugs-related deaths in 2000\u20132007: Presence of heroin, methadone, diazepam and alcohol by sex, age-group and era","volume":"19","author":"Bird","year":"2011","journal-title":"Addiction Research & Theory"},{"key":"10.1016\/j.drugpo.2015.12.024_bib0040","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.drugalcdep.2014.12.002","article-title":"Illicit use of opioid substitution drugs: Prevalence, user characteristics, and the association with non-fatal overdoses","volume":"147","author":"Bretteville-Jensen","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"4","key":"10.1016\/j.drugpo.2015.12.024_bib0045","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/ADM.0b013e31829727b2","article-title":"Prior buprenorphine experience is associated with office-based buprenorphine treatment outcomes","volume":"7","author":"Cunningham","year":"2013","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.drugpo.2015.12.024_bib0050","unstructured":"Drug Consumption Rooms in Germany \u2013 A Situational Assessment by the AK Konsumraum. (2011). In D. AIDS-Hilfe (Series Ed.) A. E.V. (Ed.) Retrieved from http:\/\/www.akzept.org\/pdf\/aktuel_pdf\/DKR07af1Eng.pdf."},{"key":"10.1016\/j.drugpo.2015.12.024_bib0055","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7517-9-3","article-title":"The nature of methadone diversion in England: A Merseyside case study","volume":"9","author":"Duffy","year":"2012","journal-title":"Harm Reduction Journal"},{"issue":"1\u20132","key":"10.1016\/j.drugpo.2015.12.024_bib0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/14659891.2012.734539","article-title":"Use and diversion of illicit methadone \u2013 Under what circumstances does it occur, and potential risks associated with continued use of other substances","volume":"19","author":"Duffy","year":"2014","journal-title":"Journal of Substance Use"},{"key":"10.1016\/j.drugpo.2015.12.024_bib0065","series-title":"European drug report \u2013 Trends and developments","author":"EMCDDA","year":"2014"},{"issue":"12","key":"10.1016\/j.drugpo.2015.12.024_bib0070","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1016\/j.addbeh.2013.08.008","article-title":"Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland","volume":"38","author":"Genberg","year":"2013","journal-title":"Addictive Behaviors"},{"issue":"3","key":"10.1016\/j.drugpo.2015.12.024_bib0075","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1521-0391.2012.12004.x","article-title":"Patient perspectives on choosing buprenorphine over methadone in an urban. Equal-access system","volume":"22","author":"Gryczynski","year":"2013","journal-title":"American Journal on Addictions"},{"issue":"4","key":"10.1016\/j.drugpo.2015.12.024_bib0080","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000104883","article-title":"Buprenorphine misuse among heroin and amphetamine users in Malmo, Sweden: Purpose of misuse and route of administration","volume":"13","author":"Hakansson","year":"2007","journal-title":"European Addiction Research"},{"issue":"6","key":"10.1016\/j.drugpo.2015.12.024_bib0085","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.drugpo.2012.10.003","article-title":"Methadone diversion as a protective strategy: The harm reduction potential of \u2018generous constraints\u2019","volume":"24","author":"Harris","year":"2013","journal-title":"International Journal of Drug Policy"},{"issue":"2","key":"10.1016\/j.drugpo.2015.12.024_bib0090","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1360-0443.2003.00631.x","article-title":"A postmarketing study of relative abuse liability of hypnotic sedative drugs","volume":"99","author":"Jaffe","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2015.12.024_bib0095","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000259089","article-title":"EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence","volume":"1","author":"Kokkevi","year":"1995","journal-title":"European Addiction Research"},{"issue":"3","key":"10.1016\/j.drugpo.2015.12.024_bib0100","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1465-3362.2011.00304.x","article-title":"The availability, diversion and injection of pharmaceutical opioids in South Asia","volume":"30","author":"Larance","year":"2011","journal-title":"Drug and Alcohol Review"},{"issue":"3","key":"10.1016\/j.drugpo.2015.12.024_bib0105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.drugalcdep.2012.05.025","article-title":"Inability to access buprenorphine treatment as a risk factor for using diverted buprenorphine","volume":"126","author":"Lofwall","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.drugpo.2015.12.024_bib0110","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/ADM.0000000000000045","article-title":"A review of buprenorphine diversion and misuse: The current evidence base and experiences from around the world","volume":"8","author":"Lofwall","year":"2014","journal-title":"Journal of Addiction Medicine"},{"issue":"1\u20133","key":"10.1016\/j.drugpo.2015.12.024_bib0115","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.08.006","article-title":"Buprenorphine and methadone maintenance in jail and post-release: A randomized clinical trial","volume":"99","author":"Magura","year":"2009","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2015.12.024_bib0120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00103-009-0756-1","article-title":"Praxis, Probleme und Perspektiven der Substitutionsbehandlung Opioidabhaengiger in Deutschland","volume":"52","author":"Michels","year":"2009","journal-title":"Bundesgesundheitsbl Gesunheitsforsch \u2013 Gesundheitsschutz"},{"key":"10.1016\/j.drugpo.2015.12.024_bib0125","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-7517-4-5","article-title":"Substitution treatment for opioid addicts in Germany","volume":"4","author":"Michels","year":"2007","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.drugpo.2015.12.024_bib0130","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jsat.2015.04.010","article-title":"Prior experience with non-prescribed buprenorphine: Role in treatment entry and retention","volume":"57","author":"Monico","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.drugpo.2015.12.024_bib0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/11536020-000000000-00000","article-title":"Intravenous misuse of buprenorphine characteristics and extent among patients undergoing drug maintenance therapy","volume":"30","author":"Moratti","year":"2010","journal-title":"Clinical Drug Investigation"},{"key":"10.1016\/j.drugpo.2015.12.024_bib0140","unstructured":"Narcotic Drugs Act. Retrieved from http:\/\/www.bmg.bund.de\/fileadmin\/dateien\/Downloads\/Gesetze_und_Verordnungen\/GuV\/N\/Narcotic_Drugs_18_12_2009.pdf, 2009."},{"key":"10.1016\/j.drugpo.2015.12.024_bib0145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1747-597X-9-13","article-title":"When higher doses in opioid replacement treatment are still inadequate \u2013 Association to multidimensional illness severity: A cohort study [Research Support Non-U.S. Gov\u2019t]","volume":"9","author":"Reimer","year":"2014","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"key":"10.1016\/j.drugpo.2015.12.024_bib0150","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7517-10-27","article-title":"Illicit use of methadone and buprenorphine among adolescents and young adults in Sweden","volume":"10","author":"Richert","year":"2013","journal-title":"Harm Reduction Journal"},{"issue":"4","key":"10.1016\/j.drugpo.2015.12.024_bib0155","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000149631","article-title":"Illicit methadone use and abuse in young people accessing treatment for opiate dependence","volume":"14","author":"Roche","year":"2008","journal-title":"European Addiction Research"},{"issue":"6","key":"10.1016\/j.drugpo.2015.12.024_bib0160","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.drugpo.2013.04.006","article-title":"Non-prescribed use of substitution medication among German drug users \u2013 Prevalence, motives and availability [Research Support, Non-U.S. Gov\u2019t]","volume":"24","author":"Schmidt","year":"2013","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2015.12.024_bib0165","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1747-597X-8-26","article-title":"Structural barriers in the context of opiate substitution treatment in Germany \u2013 A survey among physicians in primary care","volume":"8","author":"Schulte","year":"2013","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"1","key":"10.1016\/j.drugpo.2015.12.024_bib0170","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000320576","article-title":"Barriers to opioid substitution treatment access, entry and retention: A survey of opioid users, patients in treatment, and treating and non-treating physicians","volume":"17","author":"Stover","year":"2011","journal-title":"European Addiction Research"},{"issue":"1\u20132","key":"10.1016\/j.drugpo.2015.12.024_bib0175","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3109\/10826080903080664","article-title":"Diversion and injection of methadone and buprenorphine among clients in public opioid treatment clinics in New South Wales, Australia [Research Support Non-U.S. Gov\u2019t]","volume":"45","author":"Winstock","year":"2010","journal-title":"Substance Use & Misuse"},{"issue":"4","key":"10.1016\/j.drugpo.2015.12.024_bib0180","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/10550490802138913","article-title":"Infrequent illicit methadone use among stimulant-using patients in methadone maintenance treatment programs: A national drug abuse treatment clinical trials network study [Multicenter Study Randomized Controlled Trial Research Support, N.I.H., Extramural]","volume":"17","author":"Wu","year":"2008","journal-title":"American Journal on Addictions"},{"issue":"1","key":"10.1016\/j.drugpo.2015.12.024_bib0185","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1874473711104010028","article-title":"Buprenorphine and buprenorphine\/naloxone diversion, misuse, and illicit use: An international review [Research Support, N.I.H., Extramural Research Support U.S. Gov\u2019t, P.H.S. Review]","volume":"4","author":"Yokell","year":"2011","journal-title":"Current Drug Abuse Reviews"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395915003771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395915003771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T08:22:00Z","timestamp":1537086120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395915003771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":37,"alternative-id":["S0955395915003771"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2015.12.024","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-prescribed use of opioid substitution medication: Patterns and trends in sub-populations of opioid users in Germany","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2015.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}